The CPT1C-mediated fatty acid β-oxidation played a critical role in miR-377-3p inhibition of HCC growth and metastasis, which supports the miR-377-3p/CPT1C axis as a novel target for the treatment of HCC. Here, CPT1C is linked to hepatocellular carcinoma.